Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Gains from Sales and Divestitures (2016 - 2025)

Merit Medical Systems (MMSI) has disclosed Gains from Sales and Divestitures for 13 consecutive years, with $95000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 102.13% to $95000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95000.0 through Dec 2025, up 102.13% year-over-year, with the annual reading at $95000.0 for FY2025, 102.13% up from the prior year.
  • Gains from Sales and Divestitures hit $95000.0 in Q4 2025 for Merit Medical Systems, up from $47000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $95000.0 in Q4 2025 to a low of $26000.0 in Q4 2022.
  • Historically, Gains from Sales and Divestitures has averaged $52600.0 across 5 years, with a median of $47000.0 in 2024.
  • Biggest five-year swings in Gains from Sales and Divestitures: decreased 23.53% in 2022 and later skyrocketed 134.62% in 2023.
  • Year by year, Gains from Sales and Divestitures stood at $34000.0 in 2021, then decreased by 23.53% to $26000.0 in 2022, then surged by 134.62% to $61000.0 in 2023, then decreased by 22.95% to $47000.0 in 2024, then surged by 102.13% to $95000.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for MMSI at $95000.0 in Q4 2025, $47000.0 in Q4 2024, and $61000.0 in Q4 2023.